Status:
COMPLETED
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- Diagnosed with open-angle glaucoma (with ot without pseudoexfoliation or pigment dispersion component) or ocular hypertension
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Under 18
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00287521
Start Date
November 1 2005
End Date
February 1 2006
Last Update
March 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United States Investigative Sites in Texas and Other States
Fort Worth, Texas, United States, 76180